Home » Newsletters » BioWorld Science

BioWorld Science

March 18, 1997

View Archived Issues

Faulding half-yearly announcement

Ergo Science reports financial results for fourth-quarter and year-end 1996

Genset reports 1996 year-end financial results

ProCyte reports fourth-quarter and year-end results

Salix Holdings reports 1996 financial results

Geron Corp. reports 1996 financial results

ONYX Pharmaceuticals reports 1996 financial results

Antihepatitis agents from Mitsubishi Chemical

Taisho claims orally active antiplatelet agents

Neuroprotective, analgesic and antitussive agents from Toray

Antiatherosclerotic compounds described by Fuji Photo Film

Roche prepares new antiviral agents

Peptides for Japanese cedar allergies reported by Sankyo and Hayashibara

Differentiation-inducing retinoid-related compounds disclosed by Eisai

Pharmacokinetics and hemodynamic effects of hBNP in CHF

Pharmacokinetics of paracalcin in patients undergoing hemodialysis

Oral and intravenous pharmacokinetics of SDZ-HTF-919 in humans

Human pharmacokinetics and metabolism of clevidipine

Phase II/III results for i.v. cidofovir in CMV retinitis

BMS-186716 associated with potent, long-lasting NEP/ACE inhibition in humans

Lidocaine patch superior to placebo during dental scaling

Therapeutic potential of PAF antagonists in cardiac diseases

Preliminary clinical results with CI-1000

Topical anesthesia with liposome-encapsulated tetracaine

Pharmacodynamic effects of xemilofiban in cirrhotics

Pharmacokinetics and safety of BMS-180680

Pharmacodynamics and safety of the dopamine agonist CI-1007

Combination therapy for idiopathic intractable hiccup

Pharmacokinetics of flavopiridol in patients

Lanepitant not effective in migraine

Pharmacokinetic model described for BMS-188667

New clot buster comparable to t-PA in AMI

Avonex approved by European Commission

Roberts' Agrylin approved by FDA

Corixa and SmithKline Beecham collaborate on vaccine research

Phytera acquires Auda

Biofield in discussions with FDA for breast cancer diagnostic device

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...